CVS pharmacy benefit manager must pay $22M in oncology treatment fees

The Food and Drug Administration on Monday approved a blood test to detect colorectal cancer in individuals age 45 and older, adding another screening option for the second-most common cause of U.S. cancer deaths.

By |2024-08-12T09:31:17-04:00August 12th, 2024|Latest News|0 Comments

Some ‘inconvenient’ truths about pharmacy benefit managers

The Food and Drug Administration on Monday approved a blood test to detect colorectal cancer in individuals age 45 and older, adding another screening option for the second-most common cause of U.S. cancer deaths.

By |2024-08-12T09:30:23-04:00August 12th, 2024|Latest News|0 Comments

Rising costs, low reimbursement lead to hundreds of rural hospital closures

The Food and Drug Administration on Monday approved a blood test to detect colorectal cancer in individuals age 45 and older, adding another screening option for the second-most common cause of U.S. cancer deaths.

By |2024-08-12T09:29:34-04:00August 12th, 2024|Latest News|0 Comments

OPINION: Pharmacy benefit managers are maximizing profits, not keeping health care costs down

The Food and Drug Administration on Monday approved a blood test to detect colorectal cancer in individuals age 45 and older, adding another screening option for the second-most common cause of U.S. cancer deaths.

By |2024-08-12T09:28:52-04:00August 12th, 2024|Latest News|0 Comments

Medicare Advantage Plans Denied a Larger Share of Prior Authorization Requests in 2022 Than in Prior Years

The Food and Drug Administration on Monday approved a blood test to detect colorectal cancer in individuals age 45 and older, adding another screening option for the second-most common cause of U.S. cancer deaths.

By |2024-08-09T09:14:04-04:00August 9th, 2024|Latest News|0 Comments

Oncology Code Changes in 2025 ICD-10-CM Update Include Lymphoma and More

The Food and Drug Administration on Monday approved a blood test to detect colorectal cancer in individuals age 45 and older, adding another screening option for the second-most common cause of U.S. cancer deaths.

By |2024-08-09T09:12:05-04:00August 9th, 2024|Latest News|0 Comments

In States With Health Care Spending Targets, Spending Growth Moderated In 2022 But Still Exceeded Targets

The Food and Drug Administration on Monday approved a blood test to detect colorectal cancer in individuals age 45 and older, adding another screening option for the second-most common cause of U.S. cancer deaths.

By |2024-08-09T09:10:35-04:00August 9th, 2024|Latest News|0 Comments